![]() |
市场调查报告书
商品编码
1370618
生物样本库市场- 按产品[设备(储存、样本分析、处理、运输)、消耗品、服务、软体]、样本(血液、组织、细胞系)、应用(再生医学)、储存类型、最终用户、全球预测(2023-2032)Biobanking Market - By Product [Equipment (Storage, Sample Analysis, Processing, Transport), Consumable, Service, Software], Sample (Blood, Tissue, Cell Line), Application (Regenerative Medicine), Storage Type, End-user, Global Forecast (2023-2032) |
从2023 年到2032 年,生物样本库市场将以7.2% 的复合年增长率增长。对个人化医疗、基因组学和药物发现的日益关注,需要广泛的生物样本库来储存和分析,这将推动市场向前发展。
对生物标记识别和疾病研究的需求不断增长,以及生物银行、研究机构和製药公司之间的合作不断增加,推动了业务扩张。
认识到保存生物样本对于未来研究和医学进步的重要性将吸引投资并推动生物样本库产业的成长。 2021 年 10 月,赛默飞世尔科技推出了一系列合规、可持续的血库冰箱,专门用于储存血液和相关样本,以造福医疗保健专业人员和临床研究人员。
整个生物样本库市场根据产品和服务、样本类型、应用、储存类型、最终用户和地区进行划分。
到 2032 年,消耗品产品和服务领域的复合年增长率将达到 6.8%。这是由于对样本采集和储存解决方案的需求不断增长。研究、诊断和药物开发中对样品保存的需求不断增长,将促进该领域的成长。
根据样本类型,到 2032 年,人体组织样本领域的复合年增长率将达到 7.3%。对生物标记研究和个人化医疗的不断增长的需求将推动该领域的成长。为了推进医学研究和开发有针对性的治疗方法,对保存完好的人体组织样本的需求不断增长,也将促进该领域的成长。
到 2032 年,由于对有据可查的样本的需求不断增长,以推进药物发现和精准医疗,临床研究应用领域的复合年增长率将达到 7.5%。生物样本库和研究机构之间的合作以及临床试验的扩大将进一步促进该领域的成长。
从地区来看,亚太地区生物样本库市场在分析期间将以 7.5% 的复合年增长率成长。不断增加的研究活动,特别是基因组学和个人化医学的研究活动,将推动该地区对生物样本库的需求。此外,与国际研究机构加强合作以及日益认识到生物样本库对医学研究的重要性也将影响区域产业动态。
The biobanking market will grow at a 7.2% CAGR from 2023 to 2032. Increasing focus on personalized medicine, genomics, and drug discovery, necessitating extensive biorepositories for large-scale sample storage and analysis will drive the market ahead.
The growing demand for biomarker identification and disease research, alongside collaborations between biobanks, research institutions, and pharmaceutical companies have increased, fueling business expansion.
The recognition of the importance of preserving biological specimens for future studies and medical advancements will attract investments and drive growth in the biobanking industry. In October 2021, Thermo Fisher Scientific introduced a range of compliant, sustainable blood bank refrigerators tailored for the storage of blood and related samples, for the benefit of healthcare professionals and clinical researchers.
The overall biobanking market is segregated based on product & service, sample type, application, storage type, end-user, and region.
The consumables product & service segment will exhibit a 6.8% CAGR through 2032. This is attributed to the increasing demand for sample collection and storage solutions. The rising need for sample preservation in research, diagnostics, and drug development will augment growth in the segment.
Based on sample type, the human tissues sample segment will depict a 7.3% CAGR through 2032. The expanding need for biomarker research and personalized medicine will drive growth in the segment. The accelerating demand for well-preserved human tissue samples to advance medical research and develop targeted treatments will also foster growth across this segment.
The clinical research application segment will reflect 7.5% CAGR through 2032, driven by the increasing demand for well-documented samples to advance drug discovery and precision medicine. Collaborations between biobanks and research institutions and the expansion of clinical trials will further augment growth in the segment.
Regionally, the Asia Pacific biobanking market will grow at 7.5% CAGR during the analysis period. Rising research activities, especially in genomics and personalized medicine, will drive the demand for biorepositories in the region. In addition, increasing collaborations with international research institutions and the growing awareness of the importance of biobanking for medical research will also influence regional industry dynamics.